[Federal Register Volume 82, Number 132 (Wednesday, July 12, 2017)]
[Notices]
[Page 32169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14612]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-16-2017]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Authorization 
of Production Activity; Bristol-Myers Squibb Holdings Pharma, Ltd. 
(Pharmaceuticals); Manati, Puerto Rico

    On March 6, 2017, Bristol-Myers Squibb Holdings Pharma, Ltd. 
submitted a notification of proposed production activity to the FTZ 
Board within Subzone 7J, in Manati, Puerto Rico.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (82 FR 13578, March 14, 2017). On July 
5, 2017, the applicant was notified of the FTZ Board's decision that no 
further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: July 7, 2017.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2017-14612 Filed 7-11-17; 8:45 am]
 BILLING CODE 3510-DS-P